Stay updated on pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.

Latest updates to the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page version label was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check23 days agoChange DetectedRemoved the 'Prostate cancer' topic and the related 'MedlinePlus Genetics' topics from the page. These are related topics/links that provided disease context and additional resources.SummaryDifference0.2%

- Check30 days agoChange DetectedThe page adds Prostate cancer as a related topic and MedlinePlus Genetics, and updates the revision tag from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check37 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 was removed from the page's revision history.SummaryDifference0.1%

- Check44 days agoChange DetectedGlossary feature added to improve understanding on the page and revision metadata updated to v3.4.0, replacing the previous QC label variant. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check59 days agoChange DetectedThe study protocol document version was updated from v3.3.3 to v3.3.4. This is a minor administrative update to the study documents.SummaryDifference0.1%

Stay in the know with updates to pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.